DK2786990T3 - 2-AMINED METHYLE OR 2-ESTERIFIED METHYLENE-TANSHINON DERIVATIVES, AND METHOD OF PREPARING AND USING THEREOF - Google Patents

2-AMINED METHYLE OR 2-ESTERIFIED METHYLENE-TANSHINON DERIVATIVES, AND METHOD OF PREPARING AND USING THEREOF Download PDF

Info

Publication number
DK2786990T3
DK2786990T3 DK12854507.6T DK12854507T DK2786990T3 DK 2786990 T3 DK2786990 T3 DK 2786990T3 DK 12854507 T DK12854507 T DK 12854507T DK 2786990 T3 DK2786990 T3 DK 2786990T3
Authority
DK
Denmark
Prior art keywords
tanshinone
methyl
formula
compound
pharmaceutically acceptable
Prior art date
Application number
DK12854507.6T
Other languages
Danish (da)
English (en)
Inventor
Rongzhen Xu
Frank Rong
Fuwen Xie
Hongxi Lai
Original Assignee
Hangzhou Bensheng Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hangzhou Bensheng Pharmaceutical Co Ltd filed Critical Hangzhou Bensheng Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DK2786990T3 publication Critical patent/DK2786990T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
DK12854507.6T 2011-11-30 2012-11-30 2-AMINED METHYLE OR 2-ESTERIFIED METHYLENE-TANSHINON DERIVATIVES, AND METHOD OF PREPARING AND USING THEREOF DK2786990T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2011083261 2011-11-30
PCT/CN2012/085660 WO2013079022A1 (zh) 2011-11-30 2012-11-30 2-位胺化亚甲基或2-位酯化亚甲基丹参酮衍生物、及其制备方法和应用

Publications (1)

Publication Number Publication Date
DK2786990T3 true DK2786990T3 (en) 2018-11-19

Family

ID=48534682

Family Applications (1)

Application Number Title Priority Date Filing Date
DK12854507.6T DK2786990T3 (en) 2011-11-30 2012-11-30 2-AMINED METHYLE OR 2-ESTERIFIED METHYLENE-TANSHINON DERIVATIVES, AND METHOD OF PREPARING AND USING THEREOF

Country Status (6)

Country Link
US (1) US9328083B2 (enExample)
EP (1) EP2786990B1 (enExample)
JP (1) JP6149043B2 (enExample)
CN (1) CN103946217B (enExample)
DK (1) DK2786990T3 (enExample)
WO (1) WO2013079022A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013079017A1 (zh) * 2011-11-30 2013-06-06 杭州本生药业有限公司 2-位烷基或芳香基取代的丹参酮衍生物、及其制备方法和应用
CN105884723B (zh) * 2014-12-25 2019-08-02 上海三帆生物医药科技有限公司 丹参酮衍生物、其制备方法及其应用
CN105884857B (zh) * 2015-01-23 2018-10-12 上海三帆生物医药科技有限公司 丹参酮衍生物、其制备方法及其应用
CN106810593B (zh) * 2016-12-26 2018-12-04 郑州大学 一种丹参酮类化合物17位酯化衍生物及其制备工艺和应用
CN106831934B (zh) * 2016-12-26 2018-09-21 郑州大学 一种丹参酮类化合物15位酰胺类衍生物及其制备工艺和应用
CN111000851B (zh) * 2019-12-31 2021-09-07 扬州大学 丹参酮i在制备肿瘤细胞自噬诱导剂药物中的应用
CN113773289B (zh) * 2021-09-15 2023-05-12 沈阳药科大学 一种萘[1,2-b]杂环-4,5-二酮类化合物及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100387585C (zh) 2006-04-26 2008-05-14 秦引林 丹参酮ⅰ衍生物及其在制药中的应用
CN1837200A (zh) * 2006-04-26 2006-09-27 秦引林 丹参酮ⅰ衍生物及其在制药中的应用
KR20080047957A (ko) * 2006-11-27 2008-05-30 주식회사 엠디바이오알파 고혈압의 치료 및 예방을 위한 약제 조성물
CN101012270A (zh) * 2007-01-26 2007-08-08 广东工业大学 丹参酮衍生物及在制备醛糖还原酶抑制剂药物中的应用
CN101274925A (zh) * 2007-03-29 2008-10-01 中国科学院上海药物研究所 一类萘并呋喃邻醌化合物及其制备方法和用途
US20100209513A1 (en) * 2007-10-11 2010-08-19 In Geun Jo Pharmaceutical composition containing micronized particles of naphthoquinone-based compound
KR20090073381A (ko) * 2007-12-31 2009-07-03 주식회사 머젠스 심장질환의 치료 및 예방을 위한 약제 조성물

Also Published As

Publication number Publication date
JP2015500801A (ja) 2015-01-08
US9328083B2 (en) 2016-05-03
US20150126552A1 (en) 2015-05-07
EP2786990B1 (en) 2018-08-08
CN103946217B (zh) 2017-04-19
EP2786990A1 (en) 2014-10-08
WO2013079022A1 (zh) 2013-06-06
JP6149043B2 (ja) 2017-06-14
EP2786990A4 (en) 2015-07-15
CN103946217A (zh) 2014-07-23

Similar Documents

Publication Publication Date Title
EP2786990B1 (en) 2-aminated methylene or 2-esterified methylene tanshinone derivatives, and preparation method and application thereof
EP2805954B1 (en) 7-substituted hanfangichin b derivative, and preparation method and use thereof
DK2805955T3 (en) 1-OXO / ACYLATION-14-ACYLED ORIDONINE DERIVATIVE, PROCEDURE FOR PREPARING IT AND USING THEREOF
JP6043361B2 (ja) オレアノール酸アミド化誘導体、その調製方法及び使用
JP5976810B2 (ja) ５−置換テトランドリン誘導体、その調製方法及びその使用
DK2862869T3 (en) ACYLATED DERIVATIVES OF POLYPHYLLINE I, METHOD OF PREPARING IT AND USING THEREOF
CA2977559C (en) C14-hydroxyl esterified amino acid derivative of triptolide, and preparation method and use thereof
EP2786989B1 (en) 2-alkyl-or-aryl-substituted tanshinone derivatives, and preparation method and application thereof
JP5993455B2 (ja) ホモハリントニンアシル化誘導体、その調製方法及び使用
CN103450164B (zh) 格尔德霉素衍生物及其制备方法和用途
CN114085214A (zh) 索凡替尼杂质及其制备方法和用途